- Home
- POLA vs OGEN Comparison
POLA vs OGEN Comparison
Compare POLA & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POLA
- OGEN
- Stock Information
- Founded
- POLA 1979
- OGEN 1996
- Country
- POLA United States
- OGEN United States
- Employees
- POLA N/A
- OGEN N/A
- Industry
- POLA Industrial Machinery/Components
- OGEN Biotechnology: Pharmaceutical Preparations
- Sector
- POLA Miscellaneous
- OGEN Health Care
- Exchange
- POLA Nasdaq
- OGEN Nasdaq
- Market Cap
- POLA N/A
- OGEN 4.5M
- IPO Year
- POLA 2016
- OGEN N/A
- Fundamental
- Price
- POLA $0.45
- OGEN $0.34
- Analyst Decision
- POLA
- OGEN
- Analyst Count
- POLA 0
- OGEN 0
- Target Price
- POLA N/A
- OGEN N/A
- AVG Volume (30 Days)
- POLA 454.1K
- OGEN 389.1K
- Earning Date
- POLA 11-12-2024
- OGEN 11-07-2024
- Dividend Yield
- POLA N/A
- OGEN N/A
- EPS Growth
- POLA N/A
- OGEN N/A
- EPS
- POLA N/A
- OGEN N/A
- Revenue
- POLA $11,950,000.00
- OGEN $7,466.00
- Revenue This Year
- POLA $6.72
- OGEN N/A
- Revenue Next Year
- POLA N/A
- OGEN N/A
- P/E Ratio
- POLA N/A
- OGEN N/A
- Revenue Growth
- POLA N/A
- OGEN N/A
- 52 Week Low
- POLA $0.32
- OGEN $0.29
- 52 Week High
- POLA $0.98
- OGEN $7.74
- Technical
- Relative Strength Index (RSI)
- POLA 49.24
- OGEN 37.15
- Support Level
- POLA $0.44
- OGEN $0.29
- Resistance Level
- POLA $0.54
- OGEN $0.45
- Average True Range (ATR)
- POLA 0.07
- OGEN 0.04
- MACD
- POLA -0.01
- OGEN 0.02
- Stochastic Oscillator
- POLA 20.00
- OGEN 28.88
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.